IRGM and colon carcinoma: Of note, one study showed that the deletion polymorphism upstream of IRGM1 led to increased expression in some cell lines (notably, a lymphoblastoid line) while contributing to decreased expression in other cell lines (notably, a colon carcinoma cell line) [8].